KORU Medical Systems, Inc. (KRMD)
USD 3.7
(-10.19%)
USD 3.7
(-10.19%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 8.1 Million USD | -26.34% |
| 2022 | 11 Million USD | 129.69% |
| 2021 | 4.79 Million USD | 27.38% |
| 2020 | 3.76 Million USD | 42.19% |
| 2019 | 2.64 Million USD | 67.01% |
| 2018 | 1.58 Million USD | -1.67% |
| 2017 | 1.61 Million USD | 7.83% |
| 2016 | 1.49 Million USD | 17.1% |
| 2015 | 1.27 Million USD | 26.62% |
| 2014 | 1 Million USD | -0.9% |
| 2013 | 1.01 Million USD | -17.71% |
| 2012 | 1.23 Million USD | -1.5% |
| 2011 | 1.25 Million USD | 31.46% |
| 2010 | 954.22 Thousand USD | -26.53% |
| 2009 | 1.29 Million USD | -19.09% |
| 2008 | 1.6 Million USD | -5.01% |
| 2007 | 1.69 Million USD | -5.28% |
| 2006 | 1.78 Million USD | 20.01% |
| 2005 | 1.48 Million USD | -0.74% |
| 2004 | 1.49 Million USD | 10.0% |
| 2003 | 1.36 Million USD | 29.75% |
| 2002 | 1.04 Million USD | -1.17% |
| 2001 | 1.06 Million USD | 41.76% |
| 2000 | 749.02 Thousand USD | -18.29% |
| 1999 | 916.66 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 8.59 Million USD | 2.58% |
| 2024 Q1 | 8.38 Million USD | 3.4% |
| 2023 Q1 | 8.45 Million USD | -23.16% |
| 2023 Q3 | 7.92 Million USD | 0.37% |
| 2023 Q2 | 7.89 Million USD | -6.65% |
| 2023 FY | 8.1 Million USD | -26.34% |
| 2023 Q4 | 8.1 Million USD | 2.32% |
| 2022 Q3 | 10.17 Million USD | 3.39% |
| 2022 FY | 11 Million USD | 129.69% |
| 2022 Q4 | 11 Million USD | 8.18% |
| 2022 Q1 | 8.62 Million USD | 80.02% |
| 2022 Q2 | 9.83 Million USD | 14.07% |
| 2021 Q1 | 4.59 Million USD | 22.03% |
| 2021 Q2 | 3.33 Million USD | -27.35% |
| 2021 Q4 | 4.79 Million USD | 5.09% |
| 2021 Q3 | 4.55 Million USD | 36.72% |
| 2021 FY | 4.79 Million USD | 27.38% |
| 2020 Q3 | 5.49 Million USD | -35.1% |
| 2020 Q2 | 8.46 Million USD | 89.29% |
| 2020 Q4 | 3.76 Million USD | -31.51% |
| 2020 FY | 3.76 Million USD | 42.19% |
| 2020 Q1 | 4.47 Million USD | 68.99% |
| 2019 Q1 | 2.39 Million USD | 51.03% |
| 2019 Q3 | 2.7 Million USD | 20.57% |
| 2019 Q4 | 2.64 Million USD | -2.31% |
| 2019 FY | 2.64 Million USD | 67.01% |
| 2019 Q2 | 2.24 Million USD | -6.12% |
| 2018 Q1 | 1.24 Million USD | -21.72% |
| 2018 FY | 1.58 Million USD | -1.67% |
| 2018 Q2 | 1.56 Million USD | 26.16% |
| 2018 Q4 | 1.58 Million USD | 10.23% |
| 2018 Q3 | 1.43 Million USD | -8.22% |
| 2017 Q2 | 979.21 Thousand USD | -34.47% |
| 2017 Q1 | 1.49 Million USD | -14.07% |
| 2017 FY | 1.61 Million USD | 7.83% |
| 2017 Q4 | 1.58 Million USD | 26.39% |
| 2017 Q3 | 1.25 Million USD | 28.13% |
| 2016 Q2 | 1.39 Million USD | 9.14% |
| 2016 FY | 1.49 Million USD | 17.1% |
| 2016 Q3 | 1.54 Million USD | 10.59% |
| 2016 Q1 | 1.27 Million USD | -10.31% |
| 2016 Q4 | 1.73 Million USD | 12.89% |
| 2015 Q2 | 1.21 Million USD | 20.3% |
| 2015 Q1 | 1 Million USD | -27.8% |
| 2015 Q4 | 1.42 Million USD | 23.49% |
| 2015 Q3 | 1.15 Million USD | -4.96% |
| 2015 FY | 1.27 Million USD | 26.62% |
| 2014 Q3 | 1.2 Million USD | -6.71% |
| 2014 Q4 | 1.39 Million USD | 16.12% |
| 2014 Q2 | 1.28 Million USD | 26.72% |
| 2014 FY | 1 Million USD | -0.9% |
| 2014 Q1 | 1.01 Million USD | 26.25% |
| 2013 FY | 1.01 Million USD | -17.71% |
| 2013 Q4 | 805.44 Thousand USD | -2.73% |
| 2013 Q3 | 828.02 Thousand USD | 6.17% |
| 2013 Q2 | 779.89 Thousand USD | -36.88% |
| 2013 Q1 | 1.23 Million USD | -5.98% |
| 2012 Q1 | 1.25 Million USD | 8.84% |
| 2012 Q3 | 1.21 Million USD | 4.77% |
| 2012 FY | 1.23 Million USD | -1.5% |
| 2012 Q2 | 1.16 Million USD | -7.2% |
| 2012 Q4 | 1.31 Million USD | 7.76% |
| 2011 Q4 | 1.15 Million USD | 11.45% |
| 2011 FY | 1.25 Million USD | 31.46% |
| 2011 Q2 | 1.05 Million USD | 10.75% |
| 2011 Q1 | 954.22 Thousand USD | -0.25% |
| 2011 Q3 | 1.03 Million USD | -2.15% |
| 2010 Q1 | 1.29 Million USD | -4.29% |
| 2010 FY | 954.22 Thousand USD | -26.53% |
| 2010 Q4 | 956.63 Thousand USD | 0.72% |
| 2010 Q3 | 949.83 Thousand USD | -22.89% |
| 2010 Q2 | 1.23 Million USD | -5.16% |
| 2009 Q3 | 1.33 Million USD | -9.06% |
| 2009 Q4 | 1.35 Million USD | 1.78% |
| 2009 FY | 1.29 Million USD | -19.09% |
| 2009 Q1 | 1.6 Million USD | 8.12% |
| 2009 Q2 | 1.46 Million USD | -8.67% |
| 2008 Q3 | 1.49 Million USD | -11.39% |
| 2008 FY | 1.6 Million USD | -5.01% |
| 2008 Q4 | 1.48 Million USD | -0.43% |
| 2008 Q2 | 1.68 Million USD | -0.42% |
| 2008 Q1 | 1.69 Million USD | -5.18% |
| 2007 FY | 1.69 Million USD | -5.28% |
| 2007 Q4 | 1.78 Million USD | -3.27% |
| 2007 Q3 | 1.84 Million USD | 2.68% |
| 2007 Q2 | 1.79 Million USD | 0.57% |
| 2007 Q1 | 1.78 Million USD | 3.85% |
| 2006 Q4 | 1.71 Million USD | -2.65% |
| 2006 Q1 | 1.48 Million USD | 3.18% |
| 2006 FY | 1.78 Million USD | 20.01% |
| 2006 Q2 | 1.53 Million USD | 3.58% |
| 2006 Q3 | 1.76 Million USD | 14.6% |
| 2005 Q3 | 1.57 Million USD | 2.77% |
| 2005 Q2 | 1.53 Million USD | 2.24% |
| 2005 Q1 | 1.49 Million USD | 7.52% |
| 2005 Q4 | 1.44 Million USD | -8.45% |
| 2005 FY | 1.48 Million USD | -0.74% |
| 2004 Q2 | 1.38 Million USD | 1.88% |
| 2004 Q1 | 1.36 Million USD | 20.22% |
| 2004 FY | 1.49 Million USD | 10.0% |
| 2004 Q4 | 1.39 Million USD | 0.44% |
| 2004 Q3 | 1.38 Million USD | -0.01% |
| 2003 Q2 | 1.06 Million USD | 1.73% |
| 2003 Q1 | 1.04 Million USD | -2.28% |
| 2003 Q4 | 1.13 Million USD | -1.49% |
| 2003 Q3 | 1.14 Million USD | 7.7% |
| 2003 FY | 1.36 Million USD | 29.75% |
| 2002 Q1 | 1.06 Million USD | 6.33% |
| 2002 Q2 | 1.08 Million USD | 2.11% |
| 2002 Q3 | 1.07 Million USD | -0.44% |
| 2002 Q4 | 1.07 Million USD | -0.51% |
| 2002 FY | 1.04 Million USD | -1.17% |
| 2001 Q2 | 912.43 Thousand USD | 21.82% |
| 2001 Q3 | 946.98 Thousand USD | 3.79% |
| 2001 Q4 | 998.63 Thousand USD | 5.45% |
| 2001 Q1 | 749.02 Thousand USD | -7.64% |
| 2001 FY | 1.06 Million USD | 41.76% |
| 2000 Q4 | 810.99 Thousand USD | -0.44% |
| 2000 FY | 749.02 Thousand USD | -18.29% |
| 2000 Q2 | 926.76 Thousand USD | 0.0% |
| 2000 Q3 | 814.59 Thousand USD | -12.1% |
| 1999 FY | 916.66 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 93.596% |
| AngioDynamics, Inc. | 112.08 Million USD | 92.767% |
| AtriCure, Inc. | 147.76 Million USD | 94.513% |
| Avinger, Inc. | 19.97 Million USD | 59.407% |
| Azenta, Inc. | 351.22 Million USD | 97.692% |
| BioLife Solutions, Inc. | 75.05 Million USD | 89.198% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 99.803% |
| Daxor Corporation | 858.75 Thousand USD | -844.061% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | 50.299% |
| Femasys Inc. | 9.4 Million USD | 13.783% |
| GlucoTrack, Inc. | 1.7 Million USD | -374.66% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 87.39% |
| Hologic, Inc. | 4.02 Billion USD | 99.799% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.64% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 99.603% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | 83.413% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -1128.483% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -1128.483% |
| Masimo Corporation | 1.67 Billion USD | 99.516% |
| Microbot Medical Inc. | 3.82 Million USD | -111.898% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | 67.671% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 99.278% |
| Nephros, Inc. | 3.5 Million USD | -131.436% |
| NovoCure Limited | 783.63 Million USD | 98.965% |
| NEXGEL, Inc. | 4.78 Million USD | -69.288% |
| NEXGEL, Inc. | 4.78 Million USD | -69.288% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 90.623% |
| OraSure Technologies, Inc. | 52.17 Million USD | 84.461% |
| Pro-Dex, Inc. | 23.34 Million USD | 65.269% |
| Pulse Biosciences, Inc. | 16.44 Million USD | 50.698% |
| Predictive Oncology Inc. | 6.14 Million USD | -31.922% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -18.443% |
| QuidelOrtho Corporation | 3.55 Billion USD | 99.772% |
| Repligen Corporation | 853.2 Million USD | 99.05% |
| Sanara MedTech Inc. | 29.28 Million USD | 72.314% |
| STAAR Surgical Company | 102.73 Million USD | 92.109% |
| Sharps Technology, Inc. | 3.85 Million USD | -110.305% |
| Utah Medical Products, Inc. | 7.14 Million USD | -13.467% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 99.801% |
| Jin Medical International Ltd. | 8.92 Million USD | 9.156% |